ISSN: 1859 - 2872
Prevalence of non-alcoholic fatty liver disease in elderly patients attending 175 Military Hospital
Main Article Content
Keywords
Abstract
Objective: To determine the prevalence of NAFLD and its related factors in patients aged 60 years and older. Method: A cross-sectional study was conducted on 404 patients aged ≥ 60 years who visited the Senior Officials Clinic at Military Hospital 175 from August 2024 to June 2025. Result: The mean age of the study population was 70.1 ± 6.7 years, with males accounting for 74%. The prevalence of NAFLD diagnosed by ultrasound was 59.9%, predominantly mild to moderate in severity. Multivariate analysis showed that obesity, central obesity, and elevated triglycerides were independently associated with NAFLD risk. Factors such as age, gender, hypertension, and impaired glucose metabolism were not statistically significant after adjustment. Conclusion: NAFLD is a common condition in older adults and is independently associated with obesity, central obesity, elevated triglycerides, and insulin resistance. These preliminary findings support considering weight control, waist circumference management, and lipid regulation as potential targets for NAFLD prevention in the elderly
Article Details
References
2. Huang S, Hu W, Fang T (2025) The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden. PLoS One 20(6): 0325961. doi:10.1371/journal.pone.0325961.
3. Lin Y, Feng X, Cao X et al (2022) Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetol Metab Syndr 14(1): 181. doi:10.1186/s13098-022-00930-w.
4. Li Y, Adeniji NT, Fan W, Kunimoto K, Török NJ (2022) Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging. Aging Dis 13(4): 1239-1251. doi:10.14336/ad.2022.0318.
5. Danpanichkul P, Kongarin S, Permpatdechakul S, et al (2023) The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019. J Clin Med 12(20). doi:10.3390/jcm12206456.
6. Alcohol Research: Current Reviews Editorial Staff (2018) Drinking Patterns and Their Definitions. Alcohol Res 39(1): 17-18.
7. Consultation WE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403): 157-63. doi:10.1016/s0140-6736(03)15268-3.
8. Chen TP, Lai M, Lin WY, Huang KC, Yang KC (2020) Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community-based study. Journal of Gastroenterology and Hepatology 35(9): 1636-1643. doi:https://doi.org/10.1111/jgh.15073.
9. Vu H, Khanh Tuong TT, Hoang Lan N et al (2023) Association between nonalcoholic fatty liver disease and carotid intima-media thickness. Clin Ter 174(1):42-47. doi:10.7417/ct.2023.5007.
10. Chen TP, Lai M, Lin WY, Huang KC, Yang KC (2020) Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community-based study. J Gastroenterol Hepatol 35(9): 1636-1643. doi:10.1111/jgh.15073.
11. Tallarico V, Recinella G, Magalotti D, Muscari A, Zoli M, Bianchi G (2020) Prognostic value of non-alcoholic fatty liver disease in the elderly patients. Aging Clin Exp Res 32(12): 2657-2665. doi:10.1007/s40520-020-01487-2.
12. Koehler EM, Schouten JNL, Hansen BE et al (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study. Journal of Hepatology 57(6): 1305-1311. doi:10.1016/j.jhep.2012.07.028.
13. De A, Bhagat N, Mehta M, et al (2025) Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol. 15(1): 102400. doi:10.1016/j.jceh.2024.102400.
14. Song R, Hu M, Qin X et al (2023) The Roles of Lipid Metabolism in the Pathogenesis of Chronic Diseases in the Elderly. Nutrients. 15(15). doi:10.3390/nu15153433.
15. Thomas A, Thomas A (2025) Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions. Am J Lifestyle Med:15598276251346717. doi:10.1177/15598276251346717.
Article Sidebar
